Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor: 4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions-Reference-Cited by-同舟云学术

Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor: 4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions

Published:2000-03-14 Issue:7 Volume:43 Page:1380-1397
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Smaill Jeff B.¹,Rewcastle Gordon W.¹,Loo Joseph A.¹,Greis Kenneth D.¹,Chan O. Helen¹,Reyner Eric L.¹,Lipka Elke¹,Showalter H. D. Hollis¹,Vincent Patrick W.¹,Elliott William L.¹,Denny William A.¹

Affiliation:

1. Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand, and Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm990482t

Reference35 articles.

1. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma

2. Inhibitors of tyrosine kinase

Cited by 279 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic routes and clinical application of Small-Molecule HER2 inhibitors for cancer therapy;Bioorganic Chemistry;2024-10

2. The role of the methoxy group in approved drugs;European Journal of Medicinal Chemistry;2024-07

3. Pitfalls and Considerations in Determining the Potency and Mutant Selectivity of Covalent Epidermal Growth Factor Receptor Inhibitors;Journal of Medicinal Chemistry;2023-12-22

4. In silico screening of chalcone derivatives as promising EGFR-TK inhibitors for the clinical treatment of cancer;3 Biotech;2023-12-19

5. To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting Inhibitors;Current Topics in Medicinal Chemistry;2023-12